MM
Mike Mensinger sold $58K of BBNX stock
Mike Mensinger, Chief Product Officer of Beta Bionics, Inc. (BBNX), sold 2,650 shares of BBNX stock worth $58K, per an SEC Form 4 filed Oct 29, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 27, 2026, 2 days before it was made public.
BBNX has moved -37.5% since the trade date, from $21.39 to $13.36 (Nov 20, 2026 close).
- Traded
- Oct 27, 2026
- Disclosed
- Oct 29, 2026
- Filing delay
- 2 days
- Price since
- -37.5%
- Role
- Chief Product Officer
- Source
- SEC Form 4